Enhancing Patient Safety: Insights from the Latest Oncology Malpractice Risk Review
On June 1, 2026, The Doctors Company, recognized as the largest physician-owned malpractice insurer in the U.S., unveiled their latest report titled
Oncology Claims: June Malpractice Risk Review. This report is part of a monthly series that offers valuable insights aimed at improving patient safety and managing clinical risks across different medical specialties. For the year 2026, The Doctors Company has dedicated each month to exploring the malpractice risk trends specific to a distinct field, effectively utilizing empirical data from actual claims to shed light on how patient harm can occur and the factors contributing to claims of negligence.
The
Oncology Claims June Malpractice Risk Review includes three strategic analyses which mark pivotal areas of concern within oncology practices: 1)
Factors Contributing to Patient Harm; 2)
Negligence Allegations; and 3)
Case Study: Failure to Diagnose and Treat Missed Lesion.
Key Areas of Focus
1.
Factors Contributing to Patient Harm
This section identifies common factors that lead to oncology malpractice claims, emphasizing issues such as clinical judgment errors and communication breakdowns. These elements are crucial for healthcare providers to understand, as they directly impact the quality of care delivered to patients.
2.
Negligence Allegations
By examining negligence claims specific to oncology, this analysis seeks to empower healthcare professionals to preemptively identify potential risks. Through understanding the common pitfalls that could lead to malpractice claims, clinicians and staff can implement measures to mitigate these risks effectively.
3.
Case Study: Failure to Diagnose and Treat Missed Lesion
This case summary reviews the significant risks associated with delays in recognizing and managing cancerous lesions. It also addresses the contentious issues around the standard of care and causation, specifically discussing whether earlier detection could have influenced treatment options or outcomes post-diagnosis.
Julie Ritzman, Senior Vice President of Patient Safety and Risk Management at The Doctors Company, emphasizes, "Understanding how and why adverse events occur is essential to improving patient safety and reducing risk across healthcare." This statement reinforces the overarching goal of the monthly Malpractice Risk Review series: to provide actionable insights based on real malpractice data, assisting healthcare leaders in identifying vulnerabilities, enhancing communication protocols, and fostering a safer environment for patient care.
The Role of The Doctors Company
Founded and run by medical professionals, The Doctors Company is committed to promoting, safeguarding, and rewarding the practice of effective medicine. They provide necessary support to hospitals and practices navigating the complexities of the modern healthcare landscape—delivering expert guidance, resources, and comprehensive coverage. Notably, they feature an advocacy program that extends across all fifty states and federal jurisdictions, thereby affirming their commitment to a wide array of healthcare providers.
As part of a larger group, TDC Group, The Doctors Company serves over 125,000 healthcare professionals and organizations throughout the country. For those interested in the findings of the
Oncology Claims June Malpractice Risk Review and a desire to stay informed on industry trends, resources are available at their official website,
thedoctors.com.
In summary, as healthcare continues to evolve, staying abreast of malpractice risks is vital. Reports like this ensure that healthcare professionals are equipped with the information needed to comply with legal standards and most importantly, prioritize patient safety in their practices.